Empowering the CRISPR/Cas9 platform globally

ERS’s collaborative licensing approach promotes widespread adoption of CRISPR/Cas9 technology.

Non-exclusive licenses are available to companies involved in development and commercialization of CRISPR/Cas9 technology, products, and services.

Licenses are available in a wide range of fields

Pharmaceutical & Biotechnology
CROs, CMOs & Tool Providers
Companion Animal & Veterinary Applications
Agriculture & Livestock applications
Industrial & Synthetic Biology Applications

Some of our 100+ Licensees

Internal
Research

Industrial Bio
Production

CRO’s
CMO’s

Tools /
Reagents